Idexx Laboratories | IDXX - Debt


Idexx Laboratories reported $1.11B in Debt for its fiscal quarter ending in March of 2026.





Debt Change Date
Abbott USD 34.05B 20.19B Mar/2026
Accuray USD 170.24M 4.52M Sep/2024
Align Technology USD 116.04M 1.6M Mar/2026
AngioDynamics USD 6.3M 6.3M Feb/2025
Dentsply International USD 2.33B 137M Mar/2026
Dexcom USD 1.24B 900K Mar/2026
Edwards Lifesciences USD 600M 105.4M Mar/2026
Fujifilm JPY 1.03T 104.2B Mar/2026
Globus Medical USD 115.22M 3.43M Mar/2026
Henry Schein USD 3.75B 313M Mar/2026
Idexx Laboratories USD 1.11B 129.39M Mar/2026
Inogen USD 0 0 Jun/2022
Insulet USD 948.4M 300K Jun/2026
Integra LifeSciences USD 2.04B 6.27M Mar/2026
Intuitive Surgical USD 0 0 Mar/2025
Neogen USD 793.3M 374K Dec/2025
Orthofix International USD 137.23M 338K Sep/2024
Phibro Animal Health USD 474.17M 730K Sep/2024
ResMed USD 843.17M 4.55M Mar/2026
Roche Holding CHF 33.03B 1.41B Jun/2025
Steris USD 2.09B 33.5M Mar/2026
Tandem Diabetes Care USD 734.74M 290.26M Mar/2026
Teleflex USD 2.69B 39.95M Mar/2026
Thermo Fisher Scientific USD 43.16B 3.78B Mar/2026
Zoetis USD 9.24B 0 Mar/2026